Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription Articles published in Transplantation Retrieve available abstracts of 129 articles: HTML format

Single Articles

May 2024
1. ZHAN M, Liu D, Yao L, Wang W, et al
   Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway.
   Transplantation. 2024 May 10. doi: 10.1097/TP.0000000000005036.
   PubMed     Abstract available
   
   
   April 2024
2. CONCORS SJ, Hernandez PT, O'Brien C, DePaolo J, et al
   Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
   Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000005042.
   PubMed     Abstract available
   
   
   
3. EMAMAULLEE J, Bartlett JMA, Bangerth S, Etesami K, et al
   Response Regarding Application of the CHALF Score in Pediatric Acute Liver Failure.
   Transplantation. 2024;108:e66-e67.
   PubMed    
   
   
   
4. YADAV D, Lal BB, Sood V, Khanna R, et al
   Prognostication in Pediatric Acute Liver Failure Using CHALF Score-"Perspective From the Opposite Shore".
   Transplantation. 2024;108:e64-e65.
   PubMed    
   
   
   February 2024
5. BECKER EC, Siddique O, O'Sullivan DM, Dar W, et al
   Disparities in Liver Transplantation for Nonalcoholic Steatohepatitis in Women.
   Transplantation. 2024 Feb 29. doi: 10.1097/TP.0000000000004964.
   PubMed     Abstract available
   
   
   
6. ELSOKARY K, Samuel S, Koizumi N, Ortiz J, et al
   Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
   Transplantation. 2024;108:e21.
   PubMed    
   
   
   
7. CROSS-NAJAFI AA, Farag K, Chen AM, Smith LJ, et al
   The Long Road to Develop Custom-built Livers: Current Status of 3D Liver Bioprinting.
   Transplantation. 2024;108:357-368.
   PubMed     Abstract available
   
   
   November 2023
8. RASTOGI A, Gupta AA, Piplani T, Yadav KS, et al
   Hilar Anatomy in 3035 Living Liver Donors: A Novel Classification for Donor Surgery and Suitability, Hepatic Surgeries, and Hepatobiliary Interventions.
   Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004807.
   PubMed     Abstract available
   
   
   
9. MAHMUD N, Yagan L, Hoteit MA, Reddy KR, et al
   Significant Reduction in Posttransplant Hepatocellular Carcinoma Recurrence in the Post 6-Mo Waiting Policy Era.
   Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004860.
   PubMed     Abstract available
   
   
   
10. SNEIDERS D, van Dijk ARM, Darwish-Murad S, van Rosmalen M, et al
    Quantifying the Disadvantage of Small Recipient Size on the Liver Transplantation Waitlist, a Longitudinal Analysis Within the Eurotransplant Region.
    Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004804.
    PubMed     Abstract available
    
    
    
11. WANG JH, Pfeiffer RM, Musgrove D, Castenson D, et al
    Cancer Mortality Among Solid Organ Transplant Recipients in the United States During 1987-2018.
    Transplantation. 2023;107:2433-2442.
    PubMed     Abstract available
    
    
    October 2023
12. SEDKI M, Kwong A, Bhargava M, Ahmed A, et al
    Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models.
    Transplantation. 2023 Oct 30. doi: 10.1097/TP.0000000000004800.
    PubMed     Abstract available
    
    
    
13. ASCHER-BARTLETT JM, Bangerth S, Jordan S, Weaver C, et al
    CHALF Score: A Novel Tool to Rapidly Risk Stratify Children in Need of Liver Transplant Evaluation During Acute Liver Failure.
    Transplantation. 2023 Oct 23. doi: 10.1097/TP.0000000000004845.
    PubMed     Abstract available
    
    
    
14. DEEP A
    Organ Allocation in Children With Chronic Liver Disease: Quest for an Ideal Prognostic Model Continues!
    Transplantation. 2023;107:e242-e244.
    PubMed    
    
    
    
15. AHN DJ, Zeng S, Pelzer KM, Barth RN, et al
    The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System.
    Transplantation. 2023;107:e247-e256.
    PubMed     Abstract available
    
    
    
16. ZENDEL A, Renzo CD, Rocha C, Samuel B, et al
    P5.3: Successful liver transplantation using a deceased donor liver with glycogenic hepatopathy pathologic appearance.
    Transplantation. 2023;107.
    PubMed    
    
    
    
17. RODRIGUEZ-DAVALOS MI, Lopez-Verdugo F, Kasahara M, Muiesan P, et al
    International Liver Transplantation Society Global Census: First Look at Pediatric Liver Transplantation Activity Around the World.
    Transplantation. 2023;107:2087-2097.
    PubMed     Abstract available
    
    
    September 2023
18. AZOULAY D, Desterke C, Bhangui P, Serrablo A, et al
    Rescue Liver Transplantation for Posthepatectomy Liver Failure: A Systematic Review and Survey of an International Experience.
    Transplantation. 2023 Sep 26. doi: 10.1097/TP.0000000000004813.
    PubMed     Abstract available
    
    
    August 2023
19. ROSENTHAL BE, Abt PL, Schaubel DE, Reddy KR, et al
    Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
    Transplantation. 2023 Aug 28. doi: 10.1097/TP.0000000000004767.
    PubMed     Abstract available
    
    
    
20. TOYA K, Tomimaru Y, Kobayashi S, Harada A, et al
    Efficacy of Autologous Skeletal Myoblast Cell Sheet Transplantation for Liver Regeneration in Liver Failure.
    Transplantation. 2023;107:e190-e200.
    PubMed     Abstract available
    
    
    
21. TEN DAM MJM, Frederix GWJ, Ten Ham RMT, van der Laan LJW, et al
    Toward Transplantation of Liver Organoids: From Biology and Ethics to Cost-effective Therapy.
    Transplantation. 2023;107:1706-1717.
    PubMed     Abstract available
    
    
    July 2023
22. THULUVATH AJ, Duarte-Rojo A, Lai JC, Peipert J, et al
    Brief PROMIS Assessment Screens for Frailty and Predicts Hospitalizations in Liver Transplant Candidates.
    Transplantation. 2023 Jul 27. doi: 10.1097/TP.0000000000004741.
    PubMed     Abstract available
    
    
    
23. LIM WH, Ng CH, Tan DJH, Xiao J, et al
    Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver Cirrhosis.
    Transplantation. 2023 Jul 12. doi: 10.1097/TP.0000000000004718.
    PubMed     Abstract available
    
    
    
24. HASSOUNEH R, Flynn S, Shen S, Tseng M, et al
    Impact of Liver Transplantation on Adipose Tissue Compartments and Its Association With Metabolic Sequela.
    Transplantation. 2023 Jul 12. doi: 10.1097/TP.0000000000004704.
    PubMed     Abstract available
    
    
    
25. BRANAGAN WT, Norvell JP
    Assessment and Evaluation of Alcohol Use Disorder in Liver Transplant.
    Transplantation. 2023 Jul 6. doi: 10.1097/TP.0000000000004722.
    PubMed     Abstract available
    
    
    
26. CONNOR AA, Saharia A, Mobley CM, Hobeika MJ, et al
    Modern Outcomes After Liver Retransplantation: A Single-center Experience.
    Transplantation. 2023;107:1513-1523.
    PubMed     Abstract available
    
    
    June 2023
27. COTTER TG, Mitchell MC, Patel MJ, Anouti A, et al
    Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
    Transplantation. 2023 Jun 21. doi: 10.1097/TP.0000000000004701.
    PubMed     Abstract available
    
    
    
28. WANG Y, Jia L, Wei M, Lyu J, et al
    Circulating Exosomes Mediate Neurodegeneration Following Hepatic Ischemia-Reperfusion Through Inducing Microglial Pyroptosis in the Developing Hippocampus.
    Transplantation. 2023 Jun 9. doi: 10.1097/TP.0000000000004664.
    PubMed     Abstract available
    
    
    
29. CHA DI, Kim JM, Jeong WK, Yi NJ, et al
    Recurrence-free Survival After Liver Transplantation Versus Surgical Resection for Hepatocellular Carcinoma: Role of High-risk MRI Features.
    Transplantation. 2023 Jun 8. doi: 10.1097/TP.0000000000004675.
    PubMed     Abstract available
    
    
    
30. LAURENCE JM
    Context to the Analysis of High Risk of Microvascular Invasion on Liver MRI When Considering Resection or Transplantation as Treatment Options for Hepatocellular Carcinoma.
    Transplantation. 2023 Jun 8. doi: 10.1097/TP.0000000000004676.
    PubMed    
    
    
    May 2023
31. MAZUR RD, Cron DC, Chang DC, Yeh H, et al
    Impact of Median MELD at Transplant Minus 3 National Policy on Quality of Transplanted Livers for Patients With and Without Hepatocellular Carcinoma.
    Transplantation. 2023 May 16. doi: 10.1097/TP.0000000000004621.
    PubMed     Abstract available
    
    
    
32. WANG X, El Jabbour T, Chahal D, Odin JA, et al
    First Report of Immunoglobulin G4-related Hepatic Inflammatory Pseudotumor in Transplanted Liver.
    Transplantation. 2023;107:e154-e155.
    PubMed    
    
    
    April 2023
33. MAGAZ M, Giudicelli-Lett H, Rautou PE, Durand F, et al
    Reply to "Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome".
    Transplantation. 2023 Apr 24. doi: 10.1097/TP.0000000000004611.
    PubMed    
    
    
    
34. AGRAWAL D, Giri S, Sharma M
    Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Unmet Questions.
    Transplantation. 2023 Apr 24. doi: 10.1097/TP.0000000000004612.
    PubMed    
    
    
    
35. DI SANDRO S, Sposito C, Ravaioli M, Lauterio A, et al
    Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat Perspective.
    Transplantation. 2023 Apr 6. doi: 10.1097/TP.0000000000004593.
    PubMed     Abstract available
    
    
    
36. HUANG H, Chen R, Lin Y, Jiang J, et al
    Decoding Single-cell Landscape and Intercellular Crosstalk in the Transplanted Liver.
    Transplantation. 2023;107:890-902.
    PubMed     Abstract available
    
    
    March 2023
37. PALTE E, Duong JK, Remotti H, Burt J, et al
    Vibration Controlled Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation.
    Transplantation. 2023 Mar 24. doi: 10.1097/TP.0000000000004581.
    PubMed     Abstract available
    
    
    
38. CARRIER FM, Zaouter C
    Comment on: "The Supply Side of Coagulation: Fibrinogen and Bleeding in Liver Disease and Transplantation." The Known, the Unknown, the Possibly Known, and the Impossible.
    Transplantation. 2023;107:e76-e77.
    PubMed    
    
    
    
39. WALLER KMJ, Bowen DG, Strasser SI
    Transforming Genes to Protect Against Liver Disease: Will siRNA-based Therapeutics Reduce the Need for Liver Transplantation?
    Transplantation. 2023;107:556-557.
    PubMed    
    
    
    
40. WAGENER G
    The Supply Side of Coagulation: Fibrinogen and Bleeding in Liver Disease and Transplantation.
    Transplantation. 2023;107:576-577.
    PubMed    
    
    
    February 2023
41. LUND LK, Grabhorn EF, Ruther D, Buchholz A, et al
    Long-term Outcome of Pediatric Liver Transplant Recipients Who Have Reached Adulthood: A Single-center Experience.
    Transplantation. 2023 Feb 23:e004556. doi: 10.1097/TP.0000000000004556.
    PubMed     Abstract available
    
    
    
42. KWONG AJ, Kim WR, Lake J, Stock PG, et al
    Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome.
    Transplantation. 2023;107:405-409.
    PubMed     Abstract available
    
    
    January 2023
43. LERUT J, Lai Q
    Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2023 Jan 25. doi: 10.1097/TP.0000000000004488.
    PubMed    
    
    
    
44. DURKIN C, Schaubel DE, Xu Y, Mahmud N, et al
    Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2023 Jan 25. doi: 10.1097/TP.0000000000004487.
    PubMed     Abstract available
    
    
    December 2022
45. MAGAZ M, Giudicelli-Lett H, Nicoara-Farcau O, Rajoriya N, et al
    Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.
    Transplantation. 2022 Dec 9. doi: 10.1097/TP.0000000000004444.
    PubMed     Abstract available
    
    
    November 2022
46. HSU YC, Chen CH, Huang HF, Lee YT, et al
    Therapeutic Effects of Anti-PD1 Immunotherapy on Hepatocellular Carcinoma Under Administration of Tacrolimus.
    Transplantation. 2022 Nov 16. pii: 00007890-990000000-00249.
    PubMed     Abstract available
    
    
    
47. REZNICEK E, Sasaki K, Montane B, Sims A, et al
    Outcomes of Liver Transplantation in Patients with Preexisting Coronary Artery Disease.
    Transplantation. 2022 Nov 14. pii: 00007890-990000000-00247.
    PubMed     Abstract available
    
    
    
48. NIAZI SK, Brennan E, Spaulding A, Crook J, et al
    Impact of Recipient Age at Liver Transplant on Long-term Outcomes.
    Transplantation. 2022 Nov 10. pii: 00007890-990000000-00246.
    PubMed     Abstract available
    
    
    October 2022
49. CENTONZE L, Gorga G, De Carlis R, Bernasconi D, et al
    Clinical Impact of Spontaneous Portosystemic Shunts in Liver Transplantation: A Comprehensive Assessment Through Total Shunt Area Measurement.
    Transplantation. 2022 Oct 29. pii: 00007890-990000000-00227.
    PubMed     Abstract available
    
    
    
50. ODEN-BRUNSON H, McDonald MF, Godfrey E, Keeling SS, et al
    Is Liver Transplant Justified at Any MELD Score?
    Transplantation. 2022 Oct 20. pii: 00007890-990000000-00216.
    PubMed     Abstract available
    
    
    
51. WERNEBURG GT, Hettel DR, Mahajan P, Goldfarb DA, et al
    Analysis of Native Kidney Function Recovery with Renal Scintigraphy Following Simultaneous Liver-Kidney Transplantation.
    Transplantation. 2022 Oct 13. pii: 00007890-990000000-00196.
    PubMed     Abstract available
    
    
    
52. ZOU Z, Shang R, Zhou L, Du D, et al
    The Novel MyD88 Inhibitor TJ-M2010-5 Protects Against Hepatic Ischemia-reperfusion Injury by Suppressing Pyroptosis in Mice.
    Transplantation. 2022 Oct 12. pii: 00007890-990000000-00172.
    PubMed     Abstract available
    
    
    September 2022
53. THULUVATH AJ, Siddiqui O, Lai JC, Peipert J, et al
    Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver Transplantation.
    Transplantation. 2022 Sep 29. pii: 00007890-990000000-00176.
    PubMed     Abstract available
    
    
    
54. DODGE JL, Lee BT, Kassem ACZ, Biggins SW, et al
    The Conundrum of Patients With Compensated Cirrhosis Requiring Kidney Transplantation; Kidney Alone or Simultaneous Liver Kidney Transplantation.
    Transplantation. 2022 Sep 26. pii: 00007890-990000000-00171.
    PubMed     Abstract available
    
    
    
55. CARRIER FM, Deshetres A, Ferreira Guerra S, Rioux-Masse B, et al
    Preoperative Fibrinogen Level and Bleeding in Liver Transplantation for End-stage Liver Disease: A Cohort Study.
    Transplantation. 2022 Sep 23. pii: 00007890-990000000-00173.
    PubMed     Abstract available
    
    
    
56. KOUNIS I, Sebagh M, Evain M, Cailliez V, et al
    Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival.
    Transplantation. 2022 Sep 19. pii: 00007890-990000000-00165.
    PubMed     Abstract available
    
    
    August 2022
57. ICHAI P, Bouchghoul H, Laurent-Bellue A, Sacleux SC, et al
    Urgent Liver Transplantation for Acute Liver Failure in Pregnant Women: The Optimum Timing for Delivery.
    Transplantation. 2022 Aug 31. pii: 00007890-990000000-00153.
    PubMed     Abstract available
    
    
    
58. SEHJAL J, Sharples LD, Keogh RH, Walker K, et al
    Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry.
    Transplantation. 2022 Aug 26. pii: 00007890-990000000-00149.
    PubMed     Abstract available
    
    
    
59. TOVOLI F, Pallotta DP, Sansone V, Iavarone M, et al
    Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments.
    Transplantation. 2022 Aug 2. pii: 00007890-990000000-00123.
    PubMed     Abstract available
    
    
    
60. HERBST LR, Herrick-Reynolds K, Bowles Zeiser L, Lopez JI, et al
    The Landscape of Nondirected Living Liver Donation in the United States.
    Transplantation. 2022;106:1600-1608.
    PubMed     Abstract available
    
    
    July 2022
61. ZHOU S, Rao Z, Xia Y, Wang Q, et al
    CCAAT/Enhancer-binding Protein Homologous Protein Promotes ROS-mediated Liver Ischemia and Reperfusion Injury by Inhibiting Mitophagy in Hepatocytes.
    Transplantation. 2022 Jul 13. pii: 00007890-990000000-00102.
    PubMed     Abstract available
    
    
    
62. EGAWA H, Ohdan H, Saito K
    Current Status of ABO-incompatible Liver Transplantation.
    Transplantation. 2022 Jul 11. pii: 00007890-990000000-00101.
    PubMed     Abstract available
    
    
    
63. PERKONS NR, Metz DC, Siegelman ES, Yang Z, et al
    Where LI-RADS Falls Short: Two Cases of Image-diagnosed HCC, Found to Be NET on Explant.
    Transplantation. 2022;106:e350-e351.
    PubMed    
    
    
    June 2022
64. JAMIL OK, Sandikci B, Faust N, Cotter TG, et al
    Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States.
    Transplantation. 2022 Jun 29. pii: 00007890-990000000-00093.
    PubMed     Abstract available
    
    
    
65. DAVE S, Yang K, Schnickel GT, Kono Y, et al
    The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant Outcomes.
    Transplantation. 2022;106:e308-e309.
    PubMed    
    
    
    
66. PHILIP G, Hookey L, Richardson H, Flemming JA, et al
    Alcohol-associated Liver Disease Is Now the Most Common Indication for Liver Transplant Waitlisting Among Young American Adults.
    Transplantation. 2022 Jun 1. pii: 00007890-990000000-00064.
    PubMed     Abstract available
    
    
    May 2022
67. TEJEDOR M, Selzner N, Berenguer M
    Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
    Transplantation. 2022 May 16. pii: 00007890-990000000-00049.
    PubMed     Abstract available
    
    
    
68. WANG Z, Liu D, Yan Q, Liu F, et al
    Activated AXL Protects Against Hepatic Ischemia-reperfusion Injury by Upregulating SOCS-1 Expression.
    Transplantation. 2022 May 11. pii: 00007890-990000000-00043.
    PubMed     Abstract available
    
    
    
69. CANNON RM, Nassel A, Walker JT, Sheikh SS, et al
    County-level Differences in Liver-related Mortality, Waitlisting, and Liver Transplantation in the United States.
    Transplantation. 2022 May 9. pii: 00007890-990000000-00041.
    PubMed     Abstract available
    
    
    April 2022
70. YAMANA H, Inagaki A, Imura T, Nakamura Y, et al
    Cotransplantation With Adipose Tissue-Derived Stem Cells Improves Engraftment of Transplanted Hepatocytes.
    Transplantation. 2022 Apr 11. pii: 00007890-990000000-00020.
    PubMed     Abstract available
    
    
    March 2022
71. TROTTER J
    Commentary on Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022 Mar 24. pii: 00007890-900000000-95040.
    PubMed    
    
    
    
72. BERRY K, Copeland T, Ku E, Lai JC, et al
    Perioperative Delta Sodium and Post-Liver Transplant Neurological Complications in Liver Transplant Recipients.
    Transplantation. 2022 Mar 14. pii: 00007890-900000000-95051.
    PubMed     Abstract available
    
    
    
73. KAYAALP C
    Peritoneum for Middle Hepatic Vein Conduit During Living Donor Liver Transplantation.
    Transplantation. 2022;106:e194.
    PubMed    
    
    
    
74. CHOLONGITAS E
    What Is the Impact of Mammalian Target of Rapamycin Inhibitors on Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2022;106:e189.
    PubMed    
    
    
    February 2022
75. LIN SH, Lin MT, Wang CC, Chen CL, et al
    Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure.
    Transplantation. 2022;106:e163-e164.
    PubMed    
    
    
    
76. ASHKENAZI T, Stoler A, Mor E
    The Effect of Priority Given to Donor Card Holders on the Allocation of Livers for Transplant-Evidence From 7 Years of the Israeli Priority Program.
    Transplantation. 2022;106:299-307.
    PubMed     Abstract available
    
    
    January 2022
77. LAMM V, Ekser B, Vagefi PA, Cooper DKC, et al
    Bridging to Allotransplantation-Is Pig Liver Xenotransplantation the Best Option?
    Transplantation. 2022;106:26-36.
    PubMed     Abstract available
    
    
    
78. ROTELLAR F, Ciria R, Wakabayashi G, Suh KS, et al
    World Survey on Minimally Invasive Donor Hepatectomy: A Global Snapshot of Current Practices in 2370 Cases.
    Transplantation. 2022;106:96-105.
    PubMed     Abstract available
    
    
    
79. SALCEDO M, Vinaixa C, Javle M, Trapero-Marugan M, et al
    Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference.
    Transplantation. 2022;106:e3-e11.
    PubMed     Abstract available
    
    
    December 2021
80. MOHKAM K, Abdallah R, N'kontchou G, Ganne N, et al
    Influence of the ABO Blood Group System on Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2021 Dec 27. pii: 00007890-900000000-95109.
    PubMed     Abstract available
    
    
    
81. WANG H
    P.150: Alpha-1 Antitrypsin Engineered Mesenchymal Stromal Cells Improves Human Islet Survival via Regulation of Macrophage Activation.
    Transplantation. 2021;105.
    PubMed    
    
    
    
82. JARASVARAPARN C, Rusch C, Stoll J, Kulkarni S, et al
    Pediatric Subjects With Cirrhosis Are Not at a Higher Risk of Bleeding or Clotting due to a Rebalanced Hemostatic System.
    Transplantation. 2021;105.
    PubMed    
    
    
    
83. LEE EJ, Sood V, Raghu V, Squires J, et al
    Liver Transplantation From a Heterozygous Living-related Donor Into an Alpha-1 Antitrypsin Deficient Pediatric Recipient.
    Transplantation. 2021;105.
    PubMed    
    
    
    
84. BLACK K, Ziogas IA, Thurm C, Hall M, et al
    Pediatric Liver Transplant Outcomes in Alagille Syndrome: A Linked Database Analysis.
    Transplantation. 2021;105.
    PubMed    
    
    
    
85. ANTALA S, Godown J, Neighbors K, Thurm C, et al
    Multi-center Study of Peri-transplant Outcomes for Acute Liver Failure in Neonates Compared to Older Infants.
    Transplantation. 2021;105.
    PubMed    
    
    
    November 2021
86. IVANICS T, Wallace D, Abreu P, Claasen MP, et al
    Survival After Liver Transplantation: An International Comparison Between the United States and the United Kingdom in the Years 2008-2016.
    Transplantation. 2021 Nov 9. pii: 00007890-900000000-95135.
    PubMed     Abstract available
    
    
    
87. XU M, Zhou F, Ahmed O, Upadhya GA, et al
    A Novel Multidrug Combination Mitigates Rat Liver Steatosis Through Activating AMPK Pathway During Normothermic Machine Perfusion.
    Transplantation. 2021;105:e215-e225.
    PubMed     Abstract available
    
    
    
88. ZUCKERMAN J, Gorgen A, Acuna SA, Abreu P, et al
    Outcomes of Highly Selected Live Donors With a Future Liver Remnant Less Than or Equal to 30%: A Matched Cohort Study.
    Transplantation. 2021;105:2397-2403.
    PubMed     Abstract available
    
    
    October 2021
89. JAMAL M, AlMahmeed H, AlGhanem M, AlMatooq M, et al
    Organ Transplantation in Kuwait and the Recent Initiation of a Liver Program.
    Transplantation. 2021;105:2125-2127.
    PubMed    
    
    
    
90. YOELI D, Choudhury RA, Nydam TL, Pomposelli JJ, et al
    The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is It Time to Split the Difference?
    Transplantation. 2021;105:2239-2244.
    PubMed     Abstract available
    
    
    September 2021
91. LIU Y, Lei Z, Chai H, Xiang S, et al
    Thrombomodulin-mediated Inhibition of Neutrophil Extracellular Trap Formation Alleviates Hepatic Ischemia/Reperfusion Injury by Blocking TLR4 in Rats Subjected to Liver Transplantation.
    Transplantation. 2021 Sep 16. pii: 00007890-900000000-95154.
    PubMed     Abstract available
    
    
    
92. SCHLEGEL A, Foley DP, Savier E, Flores Carvalho M, et al
    Recommendations for Donor and Recipient Selection and Risk Prediction: Working Group Report From the ILTS Consensus Conference in DCD Liver Transplantation.
    Transplantation. 2021;105:1892-1903.
    PubMed     Abstract available
    
    
    August 2021
93. CROOME KP, Mathur AK, Aqel B, Yang L, et al
    Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort.
    Transplantation. 2021 Aug 30. pii: 00007890-900000000-95163.
    PubMed     Abstract available
    
    
    July 2021
94. SOGBE M, Lopez-Guerra D, Blanco-Fernandez G, Sangro B, et al
    Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: the Importance of a Wash-Out Period.
    Transplantation. 2021 Jul 19. pii: 00007890-900000000-95194.
    PubMed    
    
    
    
95. PATRONO D, Zanierato M, Avolio AW, Romagnoli R, et al
    Different Timing of Cholangiocyte and Hepatocyte Damage in Liver Preservation: Time to Implement Donor Interventions and New Preservation Techniques to Prevent Ischemic-type Biliary Lesions.
    Transplantation. 2021;105:e77-e78.
    PubMed    
    
    
    
96. MRZLJAK A, Mikulic D, Busic M, Vukovic J, et al
    Liver Transplantation in Croatia: "David Among Goliaths".
    Transplantation. 2021;105:1389-1391.
    PubMed    
    
    
    
97. B N, J H, G L, A K, et al
    O-14: Portal Hypertensive Complications after Pediatric Combined Liver-intestine Transplantation from Late Vascular Compromise of Native Portacaval Shunt: Clinical Presentation and Management.
    Transplantation. 2021;105.
    PubMed    
    
    
    June 2021
98. CENTONZE L, Lauterio A, De Carlis R, Ferla F, et al
    Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.
    Transplantation. 2021 Jun 23. pii: 00007890-900000000-95222.
    PubMed    
    
    
    
99. DEWITTE A, Defaye M, Dahmi A, Ouattara A, et al
    Prognostic impact of early recovering acute kidney injury following liver transplantation: a multicenter retrospective study.
    Transplantation. 2021 Jun 23. pii: 00007890-900000000-95219.
    PubMed     Abstract available
    
    
    
100. LIU XB, Liu H, Liu J, Cheung AKL, et al
     Cytomegalovirus Latency Exacerbated small-for-size Liver Graft Injury through Activation of CCL19/CCR7 in Hepatic Stellate Cells.
     Transplantation. 2021 Jun 2. doi: 10.1097/TP.0000000000003846.
     PubMed     Abstract available
     
     
     
101. GORGEN A, Sapisochin G
     Re: Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
     Transplantation. 2021;105:e64.
     PubMed    
     
     
     
102. SERENARI M, Ravaioli M, Cescon M
     Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
     Transplantation. 2021;105:e63.
     PubMed    
     
     
     
103. PERI AM, Magro B, van den Bogaart L, Dalla Pria A, et al
     Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19.
     Transplantation. 2021;105:e65-e67.
     PubMed    
     
     
     
104. CANNON RM, Goldberg DS, Eckhoff DE, Anderson DJ, et al
     Early Outcomes With the Liver-kidney Safety Net.
     Transplantation. 2021;105:1261-1272.
     PubMed     Abstract available
     
     
     April 2021
105. SPOSITO C, Rossi RE, Monteleone M, Coppa J, et al
     Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors.
     Transplantation. 2021 Apr 27. pii: 00007890-900000000-95264.
     PubMed     Abstract available
     
     
     
106. BUSCEMI V, De Carlis R, Lauterio A, Camozzi ML, et al
     Liver Transplantation From a Donor With Noonan Syndrome: Caveat Emptor.
     Transplantation. 2021;105:e50-e51.
     PubMed    
     
     
     
107. BONIFAZI F, Sica S, Angeletti A, Marktel S, et al
     Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group.
     Transplantation. 2021;105:686-694.
     PubMed     Abstract available
     
     
     March 2021
108. ELGHARABLY H, Ayyat KS, Okamoto T, Thuita L, et al
     Evolution of Recipient Characteristics Over 3 Decades and Impact on Survival After Lung Transplantation.
     Transplantation. 2021 Mar 18. doi: 10.1097/TP.0000000000003756.
     PubMed     Abstract available
     
     
     
109. CAMPOS-VARELA I, Gomez-Gavara C, Augustin S
     Recommendations and guidance on nutritional supplementation in the liver transplant setting.
     Transplantation. 2021 Mar 8. pii: 00007890-900000000-95312.
     PubMed     Abstract available
     
     
     
110. WEISS E, Giabicani M, Saner F
     Do Liver Transplantation Criteria Differ According to the Type of Donor and the Severity of the Recipient?
     Transplantation. 2021;105:e32.
     PubMed    
     
     
     
111. XUE Y, Liu H, Yang XX, Pang L, et al
     Inhibition of Carnitine Palmitoyltransferase 1A Aggravates Fatty Liver Graft Injury via Promoting Mitochondrial Permeability Transition.
     Transplantation. 2021;105:550-560.
     PubMed     Abstract available
     
     
     February 2021
112. DUARTE-ROJO A, Heimbach JK, Borja-Cacho D, Barone GW, et al
     Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation.
     Transplantation. 2021 Feb 23. pii: 00007890-900000000-95324.
     PubMed     Abstract available
     
     
     
113. HAN S, Cho J, Wi W, Lee KW, et al
     Sex difference in the tolerance of hepatic ischemia-reperfusion injury and hepatic estrogen receptor expression according to age and macrosteatosis in healthy living liver donors.
     Transplantation. 2021 Feb 22. doi: 10.1097/TP.0000000000003705.
     PubMed     Abstract available
     
     
     
114. SHAKED O, Demetris J, Levitsky J, Feng S, et al
     Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.
     Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003681.
     PubMed     Abstract available
     
     
     January 2021
115. IVANICS T, Salinas-Miranda E, Abreu P, Khalvati F, et al
     A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation. A Pilot Study on a Novel Biomarker.
     Transplantation. 2021 Jan 7. doi: 10.1097/TP.0000000000003605.
     PubMed     Abstract available
     
     
     
116. KING EA, Brennan DC
     The Science Is Only as Good as the Data: The Case of Fontan-associated Liver Disease.
     Transplantation. 2021;105:23-24.
     PubMed    
     
     
     
117. KIM MH, Nguyen A, Lo M, Kumar SR, et al
     Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
     Transplantation. 2021;105:18-22.
     PubMed     Abstract available
     
     
     November 2020
118. KARVELLAS CJ, Francoz C, Weiss E
     Liver Transplantation in Acute-on-Chronic Liver Failure.
     Transplantation. 2020 Nov 17. doi: 10.1097/TP.0000000000003550.
     PubMed     Abstract available
     
     
     October 2020
119. CARTIN-CEBA R, Burger C, Swanson K, Vargas H, et al
     Clinical Outcomes after Liver Transplantation in Patients with Portopulmonary Hypertension.
     Transplantation. 2020 Oct 12. doi: 10.1097/TP.0000000000003490.
     PubMed     Abstract available
     
     
     
120. WALLACE D, Cowling TE, Walker K, Suddle A, et al
     The Impact of Performance Status on Length of Hospital Stay and Clinical Complications Following Liver Transplantation.
     Transplantation. 2020 Oct 8. doi: 10.1097/TP.0000000000003484.
     PubMed     Abstract available
     
     
     July 2020
121. KAUR N, Emamaullee J, Lian T, Lo M, et al
     Impact of Morbid Obesity on Liver Transplant Candidacy and Outcomes: National and Regional Trends.
     Transplantation. 2020 Jul 31. pii: 00007890-900000000-95575.
     PubMed     Abstract available
     
     
     
122. LEE SG, Jeng LB, Saliba F, Singh Soin A, et al
     Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of Two Randomized Controlled Trials.
     Transplantation. 2020 Jul 22. pii: 00007890-900000000-95581.
     PubMed     Abstract available
     
     
     
123. ABU RMILAH A, Fencl R, Watt K, Krowka M, et al
     Association of alpha 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
     Transplantation. 2020 Jul 6. doi: 10.1097/TP.0000000000003390.
     PubMed     Abstract available
     
     
     June 2020
124. MENAHEM B, Dejardin O, Alves A, Launay L, et al
     Socioeconomic Deprivation Does Not Impact Liver Transplantation Outcome for HCC: A Survival Analysis From a National Database.
     Transplantation. 2020 Jun 9. doi: 10.1097/TP.0000000000003340.
     PubMed     Abstract available
     
     
     May 2020
125. BRAUN HJ, Dodge JL, Grab JD, Schwab ME, et al
     Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.
     Transplantation. 2020 May 18. doi: 10.1097/TP.0000000000003318.
     PubMed     Abstract available
     
     
     
126. KOSHY AN, Farouque O, Cailes B, Ko J, et al
     Prediction of Perioperative Cardiovascular Events in Liver Transplantation.
     Transplantation. 2020 May 11. doi: 10.1097/TP.0000000000003306.
     PubMed     Abstract available
     
     
     April 2020
127. RODRIGUEZ-PERALVAREZ M, Gomez-Bravo MA, Sanchez-Antolin G, De la Rosa G, et al
     Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation.
     Transplantation. 2020 Apr 27. doi: 10.1097/TP.0000000000003281.
     PubMed     Abstract available
     
     
     
128. AMIN A, Molina A, Quach L, Ito T, et al
     Liver Transplantation in Patients with Pretransplant Aspergillus Colonization: Is It Safe To Proceed?
     Transplantation. 2020 Apr 13. doi: 10.1097/TP.0000000000003276.
     PubMed     Abstract available
     
     
     February 2020
129. CRON DC, Tincopa MA, Lee JS, Waljee AK, et al
     Prevalence and patterns of opioid use before and after liver transplantation.
     Transplantation. 2020 Feb 4. doi: 10.1097/TP.0000000000003155.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.